- Home
- LTRX vs WHWK Comparison
LTRX vs WHWK Comparison
Compare LTRX & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRX
- WHWK
- Stock Information
- Founded
- LTRX 1989
- WHWK 2007
- Country
- LTRX United States
- WHWK United States
- Employees
- LTRX N/A
- WHWK N/A
- Industry
- LTRX Computer Communications Equipment
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- LTRX Telecommunications
- WHWK Health Care
- Exchange
- LTRX Nasdaq
- WHWK Nasdaq
- Market Cap
- LTRX 85.6M
- WHWK 82.4M
- IPO Year
- LTRX 2000
- WHWK N/A
- Fundamental
- Price
- LTRX $2.94
- WHWK $1.74
- Analyst Decision
- LTRX Strong Buy
- WHWK
- Analyst Count
- LTRX 4
- WHWK 0
- Target Price
- LTRX $4.13
- WHWK N/A
- AVG Volume (30 Days)
- LTRX 231.4K
- WHWK 118.0K
- Earning Date
- LTRX 09-04-2025
- WHWK 08-15-2025
- Dividend Yield
- LTRX N/A
- WHWK N/A
- EPS Growth
- LTRX N/A
- WHWK N/A
- EPS
- LTRX N/A
- WHWK 0.91
- Revenue
- LTRX $143,159,000.00
- WHWK $27,775,000.00
- Revenue This Year
- LTRX N/A
- WHWK $49.83
- Revenue Next Year
- LTRX $3.66
- WHWK N/A
- P/E Ratio
- LTRX N/A
- WHWK $1.90
- Revenue Growth
- LTRX N/A
- WHWK 16.51
- 52 Week Low
- LTRX $1.91
- WHWK $1.21
- 52 Week High
- LTRX $4.55
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- LTRX 45.96
- WHWK N/A
- Support Level
- LTRX $3.14
- WHWK N/A
- Resistance Level
- LTRX $3.40
- WHWK N/A
- Average True Range (ATR)
- LTRX 0.16
- WHWK 0.00
- MACD
- LTRX -0.04
- WHWK 0.00
- Stochastic Oscillator
- LTRX 6.12
- WHWK 0.00
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.